AVGX vs. TRVI
AVGX (Defiance Daily Target 2X Long AVGO ETF) is Leveraged Equities fund actively managed by Defiance, while TRVI (Trevi Therapeutics, Inc.) is a stock. Over the past year, AVGX returned 58.36% vs 130.31% for TRVI. At a 0.11 correlation, their price movements are largely independent.
Performance
AVGX vs. TRVI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AVGX achieves a 3.39% return, which is significantly lower than TRVI's 13.50% return.
AVGX
- 1D
- -1.88%
- 1M
- -20.84%
- YTD
- 3.39%
- 6M
- -5.26%
- 1Y
- 58.36%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TRVI
- 1D
- 5.57%
- 1M
- -6.94%
- YTD
- 13.50%
- 6M
- 11.28%
- 1Y
- 130.31%
- 3Y*
- 75.70%
- 5Y*
- 44.83%
- 10Y*
- —
AVGX vs. TRVI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
AVGX Defiance Daily Target 2X Long AVGO ETF | 3.39% | 46.98% | 54.13% |
TRVI Trevi Therapeutics, Inc. | 13.50% | 203.88% | 46.62% |
Correlation
The correlation between AVGX and TRVI is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Aug 22, 2024 | 0.11 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AVGX vs. TRVI — Risk / Return Rank
AVGX
TRVI
AVGX vs. TRVI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Defiance Daily Target 2X Long AVGO ETF (AVGX) and Trevi Therapeutics, Inc. (TRVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AVGX | TRVI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.53 | ||
| Sortino ratioReturn per unit of downside risk | -1.29 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.35 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 1.08 | 4.44 | -3.36 |
| Martin ratioReturn relative to average drawdown | 2.35 | 10.40 | -8.05 |
Loading charts...
Drawdowns
AVGX vs. TRVI - Drawdown Comparison
The maximum AVGX drawdown since its inception was -70.97%, smaller than the maximum TRVI drawdown of -95.45%. Use the drawdown chart below to compare losses from any high point for AVGX and TRVI.
Loading charts...
Drawdown Indicators
| AVGX | TRVI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -70.97% | -95.45% | +24.48% |
Max Drawdown (1Y)Largest decline over 1 year | -54.09% | -29.50% | -24.59% |
Max Drawdown (3Y)Largest decline over 3 years | — | -61.96% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -80.26% | — |
Current DrawdownCurrent decline from peak | -39.65% | -7.73% | -31.92% |
Average DrawdownAverage peak-to-trough decline | -23.11% | -61.49% | +38.38% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.90% | 12.58% | +12.32% |
Volatility
AVGX vs. TRVI - Volatility Comparison
Defiance Daily Target 2X Long AVGO ETF (AVGX) has a higher volatility of 42.68% compared to Trevi Therapeutics, Inc. (TRVI) at 13.78%. This indicates that AVGX's price experiences larger fluctuations and is considered to be riskier than TRVI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AVGX | TRVI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 42.68% | 13.78% | +28.90% |
Volatility (6M)Calculated over the trailing 6-month period | 71.57% | 39.38% | +32.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 91.19% | 60.39% | +30.80% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 106.96% | 88.26% | +18.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 106.96% | 99.35% | +7.61% |
Dividends
AVGX vs. TRVI - Dividend Comparison
AVGX's dividend yield for the trailing twelve months is around 1.60%, while TRVI has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
AVGX Defiance Daily Target 2X Long AVGO ETF | 1.60% | 1.65% | 0.81% |
TRVI Trevi Therapeutics, Inc. | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
AVGX and TRVI have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVGX has higher volatility (42.68%) compared to TRVI (13.78%). In terms of maximum drawdown, AVGX dropped -70.97% vs TRVI's -95.45%.
TRVI currently has the higher Sharpe Ratio (2.17 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AVGX and TRVI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer